Molecule intelOpportunity: ModerateEssential

Acetylcysteine

25 brands · 16 companies · product forms

ATC: R05CB01, S01XA08, V03AB23

Opportunity snapshot

Launch attractiveness
41
Market saturation
42
Price room
78
Regulatory risk
0
25
brands
16
companies
Rs 475.11
median price
15
price points
4.11x
price spread
100
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 12%

Price room

Across observed sources and strengths
CheapestRs 165.87
MedianRs 475.11
Most expensiveRs 681.51
Spread4.11×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 4.11x across 15 trusted points (Rs 165.87-681.51). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 9 live products for Acetylcysteine — each links to its own medicine page.

Why this score

Launch attractiveness

40% supply-gap(25) + 25% price-variation(78) + 20% low-competition(58) + 15% supply-disruption(0), damped by confidence(100). Higher = more attractive, less crowded opportunity.

Market saturation

16 canonical companies and 25 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 4.11x across 15 trusted points (Rs 165.87-681.51). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

No DRAP alerts on this molecule's brands.

Confidence

Full coverage.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.